Understanding Lung Cancer Screening

October 13, 2015
Cat Snyder, ASCO staff

Bernardo H.L. Goulart, MD, MS, from Fred Hutchinson Cancer Research Center in Seattle, Washington, shares highlights from his article “The Value of Lung Cancer CT Screening: It Is All About Implementation.” He explains the benefits and risks of low dose computed tomography (CT) screening for lung cancer. In addition, he offers some talking points for bringing this up with your doctor.

This is a prerecorded audio podcast, and it can be listened to online or downloaded to your computer. A transcript of this podcast is also available. For more information, visit the Cancer.Net podcast page.

This podcast is a part of a larger collection drawn from the 2015 ASCO Educational Book.


My father in law has a 5cm mass and 3cm mass in his left lung They are
going to do a biospy but going through the rectum I have never heard of
this Not sure where to search for this type of procedure They already did
a ct scan and pet scan No results of pet scan yet We do know his lymph
nodes are enlarged He is 80 years old has heart issues, only one kidney
due to kidney cancer a blood disease and is diabetic

I have received/read your comment, and am very sorry for what your father-in-law is going through, as well as the confusion surrounding his testing.
I have sent you a private email reply addressing your concerns.

Communications & Patient Information
American Society of Clinical Oncology